Concepedia
Statistics
Publications
8
Citations
422
H-Index
Active since
1998
Affiliations
Eli Lilly (United States)(Current)
Analysis Group (United States)
Lilly (China)
Narayan Rajan is an author at Eli Lilly (United States) specializing in medicine, health economics, and diabetes.
Top concepts
MedicineDiabetesHealth EconomicsHealthBusinessOncologyEconomicsLung CancerPharmacologyGlobal Health
Publications per year
1998–2016
Health state utilities in non–small cell lung cancer: An international study
Beenish Nafees, Andrew Lloyd, Sarah Dewilde et al. · Asia-Pacific Journal of Clinical Oncology · 2016 · 285 citations
Economic Evaluation of Insulin Lispro versus Neutral (Regular) Insulin Therapy Using a Willingness-To-Pay Approach
Peter Davey, David J. Grainger, Jamie MacMillan et al. · PharmacoEconomics · 1998 · 37 citations
Economics, Applied Economics, Health Economics +10
Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea
Gebra Cuyún Carter, Anna Kaltenboeck, Jasmina I. Ivanova et al. · Cancer Research and Treatment · 2016 · 23 citations · Full text
Cost-Effectiveness of Pergolide Compared to Bromocriptine in the Treatment of Parkinson's Disease: A Decision-Analytic Model
Peter Davey, Narayan Rajan, Michael Lees et al. · Value in Health · 2001 · 22 citations · Full text
Decision-analytic Model, Pharmacology, Treatment Option +7
Utilities for Type 2 Diabetes Treatment-Related Attributes in a South Korean and Taiwanese Population
Narayan Rajan, Kristina S. Boye, Meaghan Gibbs et al. · Value in Health Regional Issues · 2016 · 18 citations
Taiwanese Population, Metabolic Syndrome, Diabetes Management +12
1–5 of 8